Loading organizations...
§ Private Profile · Pittsburgh, PA, USA
clinical-stage neuroscience company developing small molecule therapeutics for Alzheimer's and other neurodegenerative diseases.
Cognition Therapeutics is a clinical-stage neuroscience company developing small molecule therapeutics for degenerative diseases of the central nervous system and retina, based in Purchase, New York, with labs in Pennsylvania. The biotechnology firm focuses on its lead oral candidate, CT1812, designed to slow disease progression in patients suffering from mild to moderate Alzheimer's disease and dementia with Lewy bodies. The enterprise has secured significant capital to fund clinical trials, including a $40 million initial public offering on the NASDAQ in 2021 and over $168 million in grants from the National Institutes of Health. Prior to its public listing, the company operated with approximately 22 employees and received early venture backing from investors such as Ogden CAP and the Pittsburgh Life Sciences Greenhouse. Cognition Therapeutics was founded in 2007 by Susan Catalano and Gilbert Rishton.
Cognition Therapeutics has raised $15.8M across 4 funding rounds.
Cognition Therapeutics has raised $15.8M in total across 4 funding rounds.
Cognition Therapeutics has raised $15.8M across 4 funding rounds. Most recently, it raised $12.0M Series B in September 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 8, 2015 | $12M Series B | Golden Seeds | ACE Fund, Ariel Southeast Angel Partners, Bios Memory Spv1, Cowtown Angels, Dolby Family Ventures, M5invest Partners, Maine Angels, Ogden CAP, Plsg Accelerator Fund, Scale Investors, Tech Coast Angels | Announced |
| Oct 11, 2013 | $140K Venture Round | Pittsburgh Life Sciences Greenhouse | — | Announced |
| Jan 20, 2011 | $2.5M Series A | Nada Jain | Innovation Works, M5invest Partners, Ogden CAP, Pittsburgh Life Sciences Greenhouse, Tech Coast Angels, Mark Breedlove, TMC Investment Company | Announced |
| Jul 17, 2009 | $1.2M Series A | Ogden CAP | Innovation Works, M5invest Partners, Pittsburgh Life Sciences Greenhouse | Announced |
Cognition Therapeutics has raised $15.8M in total across 4 funding rounds.
Cognition Therapeutics's investors include Golden Seeds, ACE Fund, Ariel Southeast Angel Partners, Bios Memory SPV1, Cowtown Angels, Dolby Family Ventures, M5Invest Partners, Maine Angels, Ogden Cap, PLSG Accelerator Fund, Scale Investors, Tech Coast Angels.